Text Box: Current Investor: Koerner Capital, LLC Investment Opportunity: Clinical stage compounds addressing large markets (pain) with unmet needs (eg, neuropathic) Experienced Management Team Founded by Nicolas G. Bazan, MD, PhD, Director Neuroscience Center of Excellence, LSU Health Sciences Center, New Orleans and Kenneth W. Narducy PhD, MBA, experienced biopharma executive Pipeline compounds (licensed from the LSU Health Sciences Center) in various stages of development Supported by private investor Strong SBIR programs funding earlier translational research and drug optimization